Welcome to The Expert Series brought to you by the Lupus Foundation of America. Our speaker today is Dr. Christine Lee, who's a member of the clinical teaching faculty and an attending physician at ...

Anti-C1q antibodies are a promising marker for the diagnosis and management of lupus nephritis. Immunological tests can differentiate proliferative from non-proliferative lupus nephritis, but anti-C1q ...

New study findings suggest that saliva and urine tests may offer non-invasive alternatives to blood tests when diagnosing lupus and monitoring individuals’ disease activity. Today, while some urine ...

A simple blood test could revolutionise treatment for lupus patients who do not respond to existing therapies, researchers say. Previous studies have shown that patients with treatment-resistant lupus ...

Improvement in results on a noninvasive urinary biomarker panel at 3 months among patients with lupus nephritis predicted a clinical response at 1 year. A noninvasive urinary biomarker panel predicts ...

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.